Bennett CL - Search Results

1

Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress.

Shortell SM, Bennett CL, Byck GR. Shortell SM, et al. Milbank Q. 1998;76(4):593-624, 510. doi: 10.1111/1468-0009.00107. Milbank Q. 1998. PMID: 9879304 Free PMC article. Review.

2

Quality improvement efforts in oncology: are we ready to begin?

Bennett CL, Crane JM; ASCO Task Force on Quality of Cancer Care. Bennett CL, et al. Cancer Invest. 2001;19(1):86-95. doi: 10.1081/cnv-100000079. Cancer Invest. 2001. PMID: 11291561

3

Quality improvement: carrots or sticks?

Scullion B, Knox K, Bennett CL. Scullion B, et al. J Clin Oncol. 1999 Dec;17(12):3856-60. J Clin Oncol. 1999. PMID: 10577864 No abstract available.

4

Performance measurement in prostate cancer care: beyond report cards.

Ullman M, Metzger CK, Kuzel T, Bennett CL. Ullman M, et al. Urology. 1996 Mar;47(3):356-65. doi: 10.1016/S0090-4295(99)80453-1. Urology. 1996. PMID: 8633402 Review.

5

Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program.

Calhoun EA, Bennett CL. Calhoun EA, et al. Oncology (Williston Park). 2003 Jan;17(1):109-14; discussion 119-21. Oncology (Williston Park). 2003. PMID: 12599935

6

Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.

Bennett CL, Calhoun EA. Bennett CL, et al. Oncologist. 2007 Apr;12(4):478-83. doi: 10.1634/theoncologist.12-4-478. Oncologist. 2007. PMID: 17470690 Clinical Trial.

7

Opportunities for disease state management in prostate cancer.

Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven A, Sharifi R, Wu Z, Knight SJ, McWilliams N, Schumock GT, Bennett CL. Pickard AS, et al. Dis Manag. 2005 Aug;8(4):235-44. doi: 10.1089/dis.2005.8.235. Dis Manag. 2005. PMID: 16117718

8

Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations.

Bennett CL, Somerfield MR, Pfister DG, Tomori C, Yakren S, Bach PB; American Society of Clinical Oncology. Bennett CL, et al. J Clin Oncol. 2003 Mar 1;21(5):937-41. doi: 10.1200/JCO.2003.07.165. J Clin Oncol. 2003. PMID: 12610197

9

The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.

Bennett CL, Bishop MR, Tallman MS, Somerfield MR, Feinglass J, Smith TJ. Bennett CL, et al. Ann Oncol. 1999 Nov;10(11):1355-9. doi: 10.1023/a:1008353130228. Ann Oncol. 1999. PMID: 10631465

10

Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?

Bennett CL, Golub R, Waters TM, Tallman MS, Rowe JM. Bennett CL, et al. Cancer Invest. 1997;15(3):227-36. doi: 10.3109/07357909709039720. Cancer Invest. 1997. PMID: 9171857 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results